Odyssean »

Moelis & Co shares owned by Odyssean

Quarter-by-quarter ownership of Moelis & Co (MC) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Moelis & Co

Tip: Access up to 7 years of quarterly data

All positions including Moelis & Co held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moelis & Co by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 44k 65.42

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Moelis & Co

BlackRock
Kayne Anderson Rudnick Investment Management
Vanguard Portfolio Management
Vanguard Capital Management
Daniel D. Thurber
State Street Corporation
London Company
Charles Schwab Investment Management
Geode Capital Management
Ameriprise Financial
HighTower Advisors
Natixis Asset Management Advisors
Madison Asset Management
Timucuan Asset Management
Dimensional Fund Advisors

View all funds holding Moelis & Co